Please login to the form below

Not currently logged in


This page shows the latest ixazomib news and features for those working in and with pharma, biotech and healthcare.

ASH18: CAR-T and drugs give new options for multiple myeloma

ASH18: CAR-T and drugs give new options for multiple myeloma

Drug therapies. There was also plenty of new data available on drug therapies for myeloma, notably Takeda’s proteasome inhibitor Ninlaro (ixazomib) which looks on course to claim a new indication

Latest news

More from news
Approximately 3 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....